{"nct_id":"NCT03254927","title":"A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2018-03-27","start_date_type":"ACTUAL","primary_completion_date":"2020-09-16","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CLDX"]}